Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial

Key facts

Sponsor

Cedars-Sinai Medical Center

Principal Investigator

Raj Makkar, MD

Cedars-Sinai Medical Center

Intervention

transcatheter aortic valve replacement (TAVR)(procedure)

Enrollment

250 enrolled

Eligibility

50 years · All sexes

Timeline

2025 – 2037

Study locations (1)

• Cedars-Sinai Medical Center, Los Angeles, California, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Familial bicuspid aortic valve

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06869954
  Towards a More Standardized Bicuspid Aortic Valve Repair: Rationale and Design of CONTOUR Trial - a Randomized Trial
  University Hospital Augsburg
• RECRUITINGNCT06830499
  Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
  Xijing Hospital
• RECRUITINGNCT06802016
  A Study of Chinese Congenital Bicuspid Aortic Valve
  Ruijin Hospital
• RECRUITINGNCT06657911
  Size Up Bicuspid with the LIra MEthod: the SUBLIME Study
  IRCCS San Raffaele
• RECRUITINGNANCT06688448
  Valvular Assessment of New Generation Aortic Replacement Devices
  Instituto Dante Pazzanese de Cardiologia
• RECRUITINGNCT06153407
  Genetic Test Based Risk Prediction of Early Calcific Aortic Valve Disease in Patients With Bicuspid Aortic Valve
  Yonsei University
• ENROLLING BY INVITATIONNCT06212050
  Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
  National University of Ireland, Galway, Ireland
• RECRUITINGNCT05739253
  Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
  China National Center for Cardiovascular Diseases

See all trials for Familial bicuspid aortic valve →